Blog - Page 3064 of 5585

ThursdayJul 26, 2012 11:19 am

Beacon Equity Research Featured Company: Liquidmetal Technologies, Inc. (LQMT)

Liquidmetal Technologies is a pioneering force in the research, development and commercialization of amorphous metals. The company’s cutting-edge class of patented alloys and processes forms the basis of high performance materials that are utilized in various medical, military, consumer, industrial and sporting goods products. Liquidmetal alloys were discovered by researchers at the California Institute of Technology. Their unique atomic structure enables applications that were not previously possible. The company’s revolutionary class of patented alloys and composites redefines performance and design paradigms that were institutionalized by traditional materials. With more than 50 U.S. patents, Liquidmetal Technologies controls the intellectual property rights…

ThursdayJul 26, 2012 11:16 am

Beacon Equity Research Featured Company: Amwest Imaging, Inc. (AMWI)

Amwest Imaging, a technology company, is chiefly engaged in providing relationship-building tools and processes to help businesses cultivate profitable relationships with customers – all through Web-based solutions. The company’s focus is on the future of cloud computing and engaging Internet technology users who are more mobile and on the move. As customer interaction is a major component of increasing sales and customer loyalty, Amwest Imaging seeks to build the best Web-based tools to help businesses keep their customers engaged and loyal to their brands. Amwest’s current portfolio consists of My Restaurant Web (MyRestaurantWeb.com), Lok Drop (LokDrop.com), and Zip Clik (ZipClik.com).…

ThursdayJul 26, 2012 9:02 am

Iteris, Inc. (ITI) Obtains $900,000 CA Contract

Iteris announced recently that it had been awarded a contract from the city of Anaheim, CA. The initially approved contract is worth $928,000 for traffic signal synchronization services, and has a ceiling value of $974,000. The project will see the deployment of Intelligent Transportation System (ITS) upgrades, as well as optimized traffic signal timing. Santa Ana, CA-based Iteris is focused on the developing and deploying of systems that reduce traffic congestion, improve the safety of surface transportation systems, and provide measurement, management, and predictive traffic analytics. Iteris has offices nationwide and in the Middle East. During the past five years,…

ThursdayJul 26, 2012 8:37 am

GlobalWise Investments, Inc. (GWIV) Selected for Membership in Esteemed Office Technology Organization

GlobalWise Investments, an industry-leading developer of cloud-based ECM (Enterprise Content Management) solutions via its wholly owned subsidiary Intellinetics, announced today that it has been accepted as a member of Technology United, a highly esteemed office technology organization. Technology United was formed as a strategic hub alliance intended to provide the best-in-class and most aggressive solutions covering the technology needs within the office space, including IT automation, security, and document management services such as those provided by GlobalWise. Technology United members include Intel, Green Hills Software, Newfield IT, and RIM, in addition to MWAi. Technology United founder, Mike Stramaglio, is CEO…

ThursdayJul 26, 2012 8:33 am

Morgans Hotel Group Co. (MHGC) Announces Location of Hudson London Property

Morgans Hotel Group confirmed rumors that its Hudson property will be located on Great Scotland Yard in St. James's, London. The company officially announced the Hudson London deal in June but finally revealed the project’s location today. Hudson London at Great Scotland Yard marks the beginning of Morgans Hotel Group's plan to introduce the brand into gateway markets around the globe. The company’s flagship location is in NYC. Slated to open in early 2015, Hudson London is in the heart of Westminster. Visitors will be steps away from some of the world’s most iconic landmarks, including Westminster Abbey, Buckingham Palace,…

ThursdayJul 26, 2012 8:29 am

Green Technology Solutions, Inc. (GTSO) Mining Subsidiary Inks LOI to Take Advantage of Chile Mining Opportunities

Green Technology Solutions, a rare earth and precious metals production company, yesterday announced that its mining subsidiary GTSO Resources has signed a letter of intent (LOI) with a Canadian entity to aid in the implementation of urban mining deals in Chile. Chile boasts rich mining opportunities, which Green Technology said makes it an ideal location for GTSO to expand operations and strategy to mine for tungsten and lithium, in particular. The Canadian organization has offices in Canada and Chile, backed by experience in the identification, structuring, and development of international business endeavors. GTSO said it plans to present the specialist…

WednesdayJul 25, 2012 1:42 pm

SmallCapVoice: Imogo Mobile Technologies Corp. (IMTC) Selects SHIFT Communications For North American Public Relations, Product Awareness

Imogo Mobile Technologies, the leader in secure mobile cloud services, announced today that it has chosen award-winning public relations firm SHIFT Communications as its North American public relations Agency of Record. SHIFT will help Imogo raise its visibility and brand awareness and build the user base for Imogo’s fully-integrated personal and business cloud computing products like ZAOffice™. The Imogo account will be serviced out of SHIFT’s Boston office, where the team will execute traditional and social media audience relations. The SHIFT program will leverage Imogo’s unique mobile, scalable, multiplatform, cloud-based solutions for enterprise companies globally. “We selected SHIFT because of…

WednesdayJul 25, 2012 1:22 pm

GreenHunter Energy, Inc. (GRH) Secures Public Pricing of 425k Shares of Series C Preferred Stock, Estimated Net Proceeds $8.3M

GreenHunter Energy is poised to drive significant shareholder returns in the burgeoning domestic/global oil and natural gas shale sector through a refined focus on the water resource services part of the company's diverse renewable energy portfolio, and reported pricing a best-efforts public offering today with projected net proceeds of some $8.3M (after typical associated expenses). The vast majority of the 425k share, non-convertible 10.0% Series C Cumulative Preferred Stock offering will be applied directly to CAPEX and operational outlays, acquisitive/developmental (direct or indirect) efforts geared to increase the company's salt water disposal architecture, beefing up the subsidiaries, handling corporate expenses,…

WednesdayJul 25, 2012 12:02 pm

International Stem Cell Corp. (ISCO) Uses Novel Business Model

The business model followed by International Stem Cell Corporation, a California based biotechnology company with a powerful new stem cell technology called parthenogenesis that promises to significantly advance the field of regenerative medicine by addressing the problem of immune-rejection, is a novel one for the biotech industry. The model uses subsidiary business units to generate revenue from the sale of products developed from scientific discoveries made by ISCO. The model is self-sustaining since it provides the revenues to support the research and development used to generate the products. In addition, it provides practical applications of the core technologies, with valuable…

WednesdayJul 25, 2012 11:57 am

CytRx Corp. (CYTR) Begins Phase 1b Clinical Trial for Aldoxorubicin in Tumor Patients

CytRx is a biopharmaceutical research and development company specializing in oncology. The company's oncology drug pipeline includes three programs in clinical development for cancer indications: aldoxorubicin, tamibarotene, and bafetinib. The company today announced the initiation of a Phase 1b clinical trial to determine the maximum tolerated dose and evaluate the preliminary efficacy of its aldoxorubicin drug (formerly INNO-206) administered in combination with the commonly used chemotherapeutic agent doxorubicin in patients with advanced solid tumors that have failed to be helped by other therapies. Aldoxorubicin is a tumor-targeting conjugate of doxorubicin. Recent animal trials using this drug combination have showed favorable…

Site Search

Company Search